Paeonol, which has been shown to have anti-inflammatory and cardiovascular protective characteristics, was used in another investigation (88, 89), was shown to block the progression of experimental AAA by inhibiting the NF-κB pathway, and the infiltration of CD68+ macrophages and CD8+ T cells was significantly reduced when paeonol was taken together (90). Here, CD8A is linked to triple-A syndrome.